Kentucky Health Center COVID-19 Survey Summary Report

Latest data from September 24, 2021

Number of Health Center respondents = 23 (92% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 24,387
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 10.00%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 3,696
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 7.68%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 88.11% 90.69%
White, Hispanic/Latino Patients 2.47% 2.33%
Black/African American, Non-Hispanic/Latino Patients 5.00% 3.76%
Black/African American, Hispanic/Latino Patients 0.09% 0.08%
Asian Patients3 0.38% 0.16%
American Indian/Alaska Native Patients3 0.05% 0.03%
Native Hawaiian/Other Pacific Islander Patients3 0.07% 0.11%
Patients with More than one race3 0.93% 0.62%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.80% 0.46%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.43% 0.38%
Unreported/Refused to Report Race and Ethnicity 1.66% 1.38%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 1,523
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 25.93%
COVID-19 Immunization Series Completed 1,764
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 27.46%
COVID-19 Immunization Series Additional 758
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 1.59%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 68.09% 66.95% 97.89%
White, Hispanic/Latino Patients 8.67% 8.96% 0.13%
Black/African American, Non-Hispanic/Latino Patients 11.88% 11.51% 1.45%
Black/African American, Hispanic/Latino Patients 0.26% 0.17% 0.00%
Asian Patients3 0.13% 0.57% 0.00%
American Indian/Alaska Native Patients3 0.13% 0.11% 0.00%
Native Hawaiian/Other Pacific Islander Patients3 0.26% 0.45% 0.00%
Patients with More than one race3 0.46% 1.36% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.04% 2.21% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.59% 0.34% 0.00%
Unreported/Refused to Report Race and Ethnicity 7.49% 7.37% 0.53%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 39.13%
1 to 24 Hours 13.04%
More Than 24 Hours 47.83%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 17.39%
Vaccine confidence 47.83%
Vaccine storage capacity 0.00%
Vaccine supply 4.35%
Other 4.35%
None 34.78%

Operations and Staff

Metrics Value
Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits 101.74%
Average Percent of Health Center Visits Conducted Virtually 15.22%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 43.48%
Number of Mobile Van Sites 18
Number of Pop-up Clinics 42
Number of School-Based Vaccination Sites 6

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 4.35%
Refer patients to another organization that provides monoclonal antibody therapies 69.57%
None 26.09%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 0.00%
Patient awareness/education 0.00%
Staffing capacity 8.70%
Therapy administration/onsite logistics 17.39%
Other 8.70%
None 73.91%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021